Copyright
©The Author(s) 2025.
World J Hepatol. Jan 27, 2025; 17(1): 101664
Published online Jan 27, 2025. doi: 10.4254/wjh.v17.i1.101664
Published online Jan 27, 2025. doi: 10.4254/wjh.v17.i1.101664
Timeframe | Event |
1 month prior admission | Patient presented with recurring upper abdominal pain, fever with chills, and significant weight loss |
Week 1 | Patient underwent a clinical evaluation and basic laboratory tests, including complete blood count and tumor markers |
Week 2 | Abdominal CT and magnetic resonance imaging scans revealed a mass in the hepatic hilum, raising suspicion of intrahepatic cholangiocarcinoma |
Week 3 | Liver biopsies, performed twice, showed no malignant cells but revealed significant eosinophilic infiltration |
Week 4 | Serologic testing was positive for Fasciola hepatica; treatment with triclabendazole was initiated |
6 months later | The patient exhibited marked symptom improvement, weight gain, and complete resolution of the hepatic mass on imaging studies. Furthermore, serologic testing for Fasciola sp. IgG yielded negative results, and stool examinations for parasitic identification were also negative |
- Citation: Le KL, Tran MQ, Pham TN, Duong NNQ, Dinh TT, Le NK. Hepatic eosinophilic pseudotumor due to Fasciola hepatica infection mimicking intrahepatic cholangiocarcinoma: A case report. World J Hepatol 2025; 17(1): 101664
- URL: https://www.wjgnet.com/1948-5182/full/v17/i1/101664.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i1.101664